CS39092A3 - IgE RECEPTOR ANTIBODIES - Google Patents

IgE RECEPTOR ANTIBODIES Download PDF

Info

Publication number
CS39092A3
CS39092A3 CS92390A CS39092A CS39092A3 CS 39092 A3 CS39092 A3 CS 39092A3 CS 92390 A CS92390 A CS 92390A CS 39092 A CS39092 A CS 39092A CS 39092 A3 CS39092 A3 CS 39092A3
Authority
CS
Czechoslovakia
Prior art keywords
subunit
fragment
ige
monoclonal antibody
antibody
Prior art date
Application number
CS92390A
Other languages
Czech (cs)
English (en)
Inventor
Richard Anthony Chizzonite
John Hakimi
Jarema Petre Kochan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS39092A3 publication Critical patent/CS39092A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CS92390A 1991-02-11 1992-02-10 IgE RECEPTOR ANTIBODIES CS39092A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65393691A 1991-02-11 1991-02-11

Publications (1)

Publication Number Publication Date
CS39092A3 true CS39092A3 (en) 1992-09-16

Family

ID=24622869

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92390A CS39092A3 (en) 1991-02-11 1992-02-10 IgE RECEPTOR ANTIBODIES

Country Status (20)

Country Link
EP (1) EP0499112A1 (fr)
JP (1) JPH05252988A (fr)
KR (1) KR920016105A (fr)
AR (1) AR245784A1 (fr)
AU (1) AU652024B2 (fr)
BR (1) BR9200442A (fr)
CA (1) CA2059842A1 (fr)
CS (1) CS39092A3 (fr)
FI (1) FI920565A (fr)
HU (1) HUT63205A (fr)
IE (1) IE920434A1 (fr)
IL (1) IL100869A0 (fr)
IS (1) IS3813A (fr)
MX (1) MX9200526A (fr)
NO (1) NO920523L (fr)
NZ (1) NZ241552A (fr)
RO (1) RO109707B1 (fr)
UY (1) UY23374A1 (fr)
YU (1) YU13392A (fr)
ZA (1) ZA92800B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
DE69405251T2 (de) * 1993-12-10 1998-02-05 Genentech Inc Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US7759133B2 (en) 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
US20030166568A1 (en) * 2000-03-23 2003-09-04 Franz Kricek Organic compounds
CA2454307A1 (fr) * 2001-07-19 2003-01-30 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anticorps de recepteur ige antihumain de type humain et fragment d'anticorps
EP2115139B8 (fr) * 2007-01-29 2015-03-18 Teknologian tutkimuskeskus VTT Oy Procede de fabrication de nouveaux reactifs a base d'ige
KR101686395B1 (ko) 2015-06-22 2016-12-15 주식회사 선일기연 Ｐｃｂ용 단자 삽입기의 삽입력 측정장치
CN105352930A (zh) * 2015-12-01 2016-02-24 深圳市绿诗源生物技术有限公司 基于amf为荧光素标记物的双酚a荧光偏振免疫分析检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof

Also Published As

Publication number Publication date
MX9200526A (es) 1992-08-01
HUT63205A (en) 1993-07-28
ZA92800B (en) 1992-10-28
AU1080292A (en) 1992-08-13
IE920434A1 (en) 1992-08-12
FI920565A0 (fi) 1992-02-11
NO920523L (no) 1992-08-12
HU9200293D0 (en) 1992-04-28
JPH05252988A (ja) 1993-10-05
IS3813A (is) 1992-08-12
KR920016105A (ko) 1992-09-24
RO109707B1 (ro) 1995-05-30
IL100869A0 (en) 1992-11-15
NZ241552A (en) 1994-03-25
BR9200442A (pt) 1992-10-20
CA2059842A1 (fr) 1992-08-12
FI920565A (fi) 1992-08-12
AU652024B2 (en) 1994-08-11
YU13392A (sh) 1995-01-31
EP0499112A1 (fr) 1992-08-19
NO920523D0 (no) 1992-02-10
UY23374A1 (es) 1992-07-30
AR245784A1 (es) 1994-02-28

Similar Documents

Publication Publication Date Title
US10934353B2 (en) Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use
EP0712863B1 (fr) Anticorps monoclonaux humanisés et chimériques que reconnaissent le récepteur du facteur de croissance épidermique (EGF-R); utilisation diagnostique et thérapeutique
US5876950A (en) Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
JP3520272B2 (ja) リンパ球機能関連抗原３のｃｄ２結合ドメイン
EP0668924B1 (fr) ANTICORPS ADAPTES AU MODELE HUMAIN DIRIGES CONTRE DES RECEPTEURS Fc D'IMMUNOGLOBULINE G SITUES SUR DES PHAGOCYTES MONONUCLERAIRES HUMAINS
KR20230052910A (ko) Ccr8 항체 및 이의 응용
US5766947A (en) Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
WO1991006570A1 (fr) MOLECULES RECEPTRICES Fc HYBRIDES
TW201839014A (zh) 抗－ilt4抗體及抗原結合片段
Yang et al. Differential expression of CD8 epitopes amongst porcine CD8‐positive functional lymphocyte subsets
US6217868B1 (en) Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen
CA2195868A1 (fr) Anticorps activant un recepteur de l'erythropoietine
CN111349163B (zh) 针对cd123的单克隆抗体
JPH07503062A (ja) 慢性関節リューマチの診断と治療用のＶα１２．１Ｔ細胞リセプターに特異的な試薬
CZ69896A3 (en) Recombinant il4 antibodies usable for treating diseases mediated by il4
CS39092A3 (en) IgE RECEPTOR ANTIBODIES
CN110028584A (zh) 针对egfr蛋白和met蛋白的双特异性抗体
CN111801354A (zh) 单克隆抗体及其使用方法
SK176198A3 (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
SK280272B6 (sk) Monoklonálna protilátka, spôsob prípravy monokloná
KR20220024211A (ko) 항-cd47 항체 및 그것의 사용
US5795961A (en) Recombinant human anti-Lewis b antibodies
EP0503646A1 (fr) Anticorps monocloneaux dressés contre l'antigène-3 associé à la fonction lymphocyte
CN117999284A (zh) 靶向tigit的单克隆抗体
US5747036A (en) Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease